US 10220042
Modified release preparations containing oxcarbazepine and derivatives thereof
granted A61KA61K2800/56A61K31/55
Quick answer
US patent 10220042 (Modified release preparations containing oxcarbazepine and derivatives thereof) held by Supernus Pharmaceuticals, Inc. expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2800/56, A61K31/55, A61K9/0073, A61K9/2013